Ingrid Glimelius
Title
Cited by
Cited by
Year
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease
LB Travis, DA Hill, GM Dores, M Gospodarowicz, FE Van Leeuwen, ...
Jama 290 (4), 465-475, 2003
6702003
Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease
LB Travis, DA Hill, GM Dores, M Gospodarowicz, FE Van Leeuwen, ...
Jama 290 (4), 465-475, 2003
6702003
Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease
LB Travis, M Gospodarowicz, RE Curtis, E Aileen Clarke, M Andersson, ...
Journal of the National Cancer Institute 94 (3), 182-192, 2002
5712002
Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma
D Molin, A Edström, I Glimelius, B Glimelius, G Nilsson, C Sundström, ...
British journal of haematology 119 (1), 122-124, 2002
2132002
Angiogenesis and mast cells in Hodgkin lymphoma
I Glimelius, A Edström, M Fischer, G Nilsson, C Sundström, D Molin, ...
Leukemia 19 (12), 2360-2362, 2005
482005
The impact of comorbid disease history on all-cause and cancer-specific mortality in myeloid leukemia and myeloma–a Swedish population-based study
M Mohammadi, Y Cao, I Glimelius, M Bottai, S Eloranta, KE Smedby
BMC cancer 15 (1), 1-12, 2015
462015
IL‐9 expression contributes to the cellular composition in Hodgkin lymphoma
I Glimelius, A Edström, RM Amini, M Fischer, G Nilsson, C Sundström, ...
European journal of haematology 76 (4), 278-283, 2006
412006
Novel treatment concepts in Hodgkin lymphoma
I Glimelius, A Diepstra
Journal of internal medicine 281 (3), 247-260, 2017
372017
Bulky disease is the most important prognostic factor in Hodgkin lymphoma stage IIB
I Glimelius, D Molin, RM Amini, A Gustavsson, B Glimelius, G Enblad
European journal of haematology 71 (5), 327-333, 2003
362003
Long‐term survival in young and middle‐aged H odgkin lymphoma patients in S weden 1992–2009—trends in cure proportions by clinical characteristics
I Glimelius, S Ekberg, M Jerkeman, ET Chang, M Björkholm, ...
American journal of hematology 90 (12), 1128-1134, 2015
352015
Autoimmune and atopic disorders and risk of classical Hodgkin lymphoma
P Hollander, K Rostgaard, KE Smedby, ET Chang, RM Amini, ...
American journal of epidemiology 182 (7), 624-632, 2015
352015
Pregnancy and the risk of relapse in patients diagnosed with Hodgkin lymphoma
CE Weibull, S Eloranta, KE Smedby, M Björkholm, SY Kristinsson, ...
Journal of Clinical Oncology 34 (4), 337-344, 2016
312016
Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time—a population-based comparative study
I Glimelius, S Ekberg, J Linderoth, M Jerkeman, ET Chang, M Neovius, ...
Journal of cancer survivorship 9 (4), 599-609, 2015
312015
Exposure to UV radiation and risk of Hodgkin lymphoma: a pooled analysis
A Monnereau, SL Glaser, CW Schupp, K Ekström Smedby, S de Sanjosé, ...
Blood 122 (20), 3492-3499, 2013
312013
The potential role of innate immunity in the pathogenesis of Hodgkin's lymphoma
G Enblad, D Molin, I Glimelius, M Fischer, G Nilsson
Hematology/oncology clinics of North America 21 (5), 805-823, 2007
312007
The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence
R Troisi, T Bjørge, M Gissler, T Grotmol, CM Kitahara, SM Myrtveit Saether, ...
Journal of internal medicine 283 (5), 430-445, 2018
302018
High proportions of PD-1+ and PD-L1+ leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome
P Hollander, P Kamper, KE Smedby, G Enblad, M Ludvigsen, ...
Blood advances 1 (18), 1427-1439, 2017
272017
Predictors of histology, tissue eosinophilia and mast cell infiltration in Hodgkin’s Lymphoma–a population‐based study
I Glimelius, J Rubin, K Rostgaard, RM Amini, M Simonsson, KM Sorensen, ...
European journal of haematology 87 (3), 208-216, 2011
262011
Effect of eosinophil cationic protein (ECP) on Hodgkin lymphoma cell lines
I Glimelius, J Rubin, M Fischer, D Molin, RM Amini, P Venge, G Enblad
Experimental hematology 39 (8), 850-858, 2011
202011
Greater attention should be paid to developing therapies for elderly patients with Hodgkin lymphoma—A population‐based study from Sweden
M Björkholm, CE Weibull, S Eloranta, KE Smedby, I Glimelius, ...
European journal of haematology 101 (1), 106-114, 2018
182018
The system can't perform the operation now. Try again later.
Articles 1–20